NU 150 Exam 2 Pharmacology Galen Nursing Actual Exam
Prep Document | 2026/2027 Edition | 200 Verified Questions -
155 Questions with Answers
NU 150 Exam 2 Pharmacology Galen Nursing 2026-155 QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive preparation guide for NU 150 Exam 2 Pharmacology at Galen College of Nursing
is meticulously curated to reflect the actual exam blueprint for the 2026/2027 academic year. It features
200 verified questions with detailed rationales, ensuring a thorough understanding of pharmacological
principles, drug classifications, and nursing implications. Designed to mirror the rigor and content
distribution of the real exam, this resource is an essential tool for achieving a top grade. Each question
is accompanied by evidence-based rationales that reinforce critical thinking and clinical application,
making it a pass-guaranteed asset for nursing students.
Key Features:
Pharmacokinetics and Pharmacodynamics: Absorption, Distribution, Metabolism, Excretion, Drug Receptors,
Agonists/Antagonists
Autonomic Nervous System Drugs: Cholinergic, Anticholinergic, Adrenergic, Antiadrenergic Agents
Cardiovascular Pharmacology: Antihypertensives, Antiarrhythmics, Cardiac Glycosides, Antianginals,
Diuretics
Respiratory Pharmacology: Bronchodilators, Corticosteroids, Expectorants, Antitussives, Decongestants
Endocrine Pharmacology: Insulin, Oral Hypoglycemics, Thyroid Medications, Corticosteroids, Sex Hormones
Neurological and Psychiatric Pharmacology: Anticonvulsants, Antiparkinson Agents, Antidepressants,
Antipsychotics, Anxiolytics
Analgesics and Anti-Inflammatory Agents: Opioids, NSAIDs, Acetaminophen, Muscle Relaxants
Antimicrobial Therapy: Antibiotics, Antivirals, Antifungals, Antituberculars, Antimalarials
Chemotherapy and Immunosuppressants: Antineoplastic Agents, Immunomodulators
Gastrointestinal Pharmacology: Antacids, Antiemetics, Laxatives, Antidiarrheals, Proton Pump Inhibitors
Hematologic Pharmacology: Anticoagulants, Antiplatelets, Thrombolytics, Hematopoietic Agents
Fluid, Electrolyte, and Acid-Base Balance: IV Fluids, Electrolyte Replacement, Acid-Base Regulators
Pediatric and Geriatric Pharmacology: Dosage Calculations, Age-Related Considerations
Pregnancy and Lactation Safety: Teratogenic Risks, FDA Categories, Safe Prescribing
Herbal and Dietary Supplements: Interactions, Adverse Effects, Nursing Implications
Medication Administration and Safety: Rights of Medication Administration, Error Prevention, High-Alert
Medications
Nursing Process in Pharmacology: Assessment, Diagnosis, Planning, Implementation, Evaluation
Patient Education and Adherence: Teaching Strategies, Cultural Considerations, Health Literacy
Updates for 2026:
- Revised to align with the latest 2026/2027 NCLEX-RN test plan and Galen College of Nursing curriculum
updates.
- Incorporated current evidence-based practice guidelines from the American Nurses Association and FDA
approvals.
- Enhanced rationales to include clinical pearls and common misconceptions to deepen understanding.
- Added new questions on emerging drug therapies and biosimilars to reflect contemporary pharmacology.
- Updated drug safety alerts and black box warnings to ensure compliance with the latest regulatory standards.
Page 1
,Abstract:
This exam preparation document is a definitive resource for nursing students enrolled in NU 150 Pharmacology at
Galen College of Nursing, targeting the 2026/2027 academic year. It compiles 200 verified questions that
comprehensively cover the pharmacological knowledge base required for safe and effective nursing practice. The
content is organized systematically, beginning with foundational principles of pharmacokinetics and
pharmacodynamics, then progressing through major drug classifications affecting body systems, and concluding
with specialized populations and medication safety. Each question is paired with a detailed rationale that explains
the correct answer, distractor analysis, and clinical application, thereby promoting higher-order thinking. The
document also includes a breakdown of content areas with corresponding question ranges and weights, ensuring
students can focus their study efforts efficiently. By integrating current guidelines and evidence-based practices,
this resource not only prepares students for exam success but also reinforces lifelong learning in pharmacology. It
is an indispensable tool for achieving a passing score and excelling in nursing practice.
Keywords:
NU 150 Exam 2, Galen Nursing Pharmacology, 2026/2027 NCLEX, Verified Questions, Detailed Rationales, Drug
Classifications, Nursing Implications, Pass Guaranteed
Answer Format:
Each question is presented in multiple-choice format with four options, followed by a comprehensive rationale
explaining why the correct answer is right and why the distractors are incorrect. Rationales include clinical context,
mechanism of action, adverse effects, and nursing considerations to reinforce learning. The answers are clearly
marked as 'Correct Answer' and are verified to align with the latest evidence-based guidelines.
Compliance Checklist:
100% verified questions aligned with the actual NU 150 Exam 2 blueprint
Detailed rationales for every question to support critical thinking
Updated to reflect 2026/2027 NCLEX-RN test plan and Galen curriculum
Includes content area breakdown with question ranges and weights
Pass guaranteed with A+ graded solutions
Content Area Overview:
Content Area Questions Key Topics Weight
Foundations of Pharmacology 1-20 Pharmacokinetics, Pharmacodynamics, Drug 10%
Interactions, Adverse Reactions
Autonomic Nervous System 21-40 Cholinergic, Anticholinergic, Adrenergic, 10%
Drugs Antiadrenergic
Cardiovascular Pharmacology 41-70 Antihypertensives, Antiarrhythmics, Cardiac 15%
Glycosides, Antianginals, Diuretics
Respiratory Pharmacology 71-85 Bronchodilators, Corticosteroids, 7.5%
Expectorants, Antitussives
Endocrine Pharmacology 86-105 Insulin, Oral Hypoglycemics, Thyroid 10%
Medications, Corticosteroids
Neurological and Psychiatric 106-130 Anticonvulsants, Antidepressants, 12.5%
Pharmacology Antipsychotics, Anxiolytics
Analgesics and 131-145 Opioids, NSAIDs, Acetaminophen, Muscle 7.5%
Anti-Inflammatory Agents Relaxants
Antimicrobial Therapy 146-165 Antibiotics, Antivirals, Antifungals, 10%
Antituberculars
Page 2
,Chemotherapy and 166-175 Antineoplastic Agents, Immunomodulators 5%
Immunosuppressants
Gastrointestinal Pharmacology 176-185 Antacids, Antiemetics, Laxatives, 5%
Antidiarrheals, PPIs
Hematologic Pharmacology 186-195 Anticoagulants, Antiplatelets, 5%
Thrombolytics, Hematopoietic Agents
Special Populations and Safety 196-200 Pediatric/Geriatric, Pregnancy/Lactation, 2.5%
Herbal Supplements, Medication Safety
Page 3
, Q1. A patient on a stable dose of warfarin is started on metronidazole for an
anaerobic infection. Three days later, the INR is 5.8. Which pharmacodynamic
principle best explains this interaction?
A. Metronidazole inhibits CYP2C9, reducing warfarin metabolism and increasing its
anticoagulant effect.
B. Metronidazole displaces warfarin from plasma protein binding sites, increasing free
drug concentration.
C. Metronidazole reduces vitamin K absorption from the gut by altering the
microbiome.
D. Metronidazole directly inhibits vitamin K epoxide reductase, potentiating warfarin's
action.
Correct Answer: A. Metronidazole inhibits CYP2C9, reducing warfarin metabolism
and increasing its anticoagulant effect.
Rationale: Metronidazole is a potent inhibitor of CYP2C9, the enzyme that metabolizes the
S-enantiomer of warfarin. This inhibition decreases warfarin clearance, leading to
elevated INR and increased bleeding risk. While other mechanisms may contribute, CYP
inhibition is the primary and most clinically significant interaction.
Why Wrong:
B - Protein binding displacement is a transient effect and not the major mechanism for
this interaction.
C - Metronidazole does not significantly alter vitamin K absorption.
D - Warfarin itself inhibits vitamin K epoxide reductase; metronidazole does not share
this mechanism.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th ed., Ch. 55, pp.
620-621.
Q2. Which medication requires the nurse to obtain a baseline ECG and serum
potassium and magnesium levels prior to initiation, and to reassess the QT interval
after each dose increase?
A. Amiodarone
B. Digoxin
C. Dofetilide
D. Lidocaine
Correct Answer: C. Dofetilide
Rationale: Dofetilide is a class III antiarrhythmic that can cause life-threatening QT
prolongation and torsades de pointes. The FDA-mandated REMS program requires
baseline and follow-up ECG and electrolyte monitoring, with dose adjustments based on
renal function and QT response. This is a unique safety protocol compared to other
antiarrhythmics.
Page 4
Prep Document | 2026/2027 Edition | 200 Verified Questions -
155 Questions with Answers
NU 150 Exam 2 Pharmacology Galen Nursing 2026-155 QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive preparation guide for NU 150 Exam 2 Pharmacology at Galen College of Nursing
is meticulously curated to reflect the actual exam blueprint for the 2026/2027 academic year. It features
200 verified questions with detailed rationales, ensuring a thorough understanding of pharmacological
principles, drug classifications, and nursing implications. Designed to mirror the rigor and content
distribution of the real exam, this resource is an essential tool for achieving a top grade. Each question
is accompanied by evidence-based rationales that reinforce critical thinking and clinical application,
making it a pass-guaranteed asset for nursing students.
Key Features:
Pharmacokinetics and Pharmacodynamics: Absorption, Distribution, Metabolism, Excretion, Drug Receptors,
Agonists/Antagonists
Autonomic Nervous System Drugs: Cholinergic, Anticholinergic, Adrenergic, Antiadrenergic Agents
Cardiovascular Pharmacology: Antihypertensives, Antiarrhythmics, Cardiac Glycosides, Antianginals,
Diuretics
Respiratory Pharmacology: Bronchodilators, Corticosteroids, Expectorants, Antitussives, Decongestants
Endocrine Pharmacology: Insulin, Oral Hypoglycemics, Thyroid Medications, Corticosteroids, Sex Hormones
Neurological and Psychiatric Pharmacology: Anticonvulsants, Antiparkinson Agents, Antidepressants,
Antipsychotics, Anxiolytics
Analgesics and Anti-Inflammatory Agents: Opioids, NSAIDs, Acetaminophen, Muscle Relaxants
Antimicrobial Therapy: Antibiotics, Antivirals, Antifungals, Antituberculars, Antimalarials
Chemotherapy and Immunosuppressants: Antineoplastic Agents, Immunomodulators
Gastrointestinal Pharmacology: Antacids, Antiemetics, Laxatives, Antidiarrheals, Proton Pump Inhibitors
Hematologic Pharmacology: Anticoagulants, Antiplatelets, Thrombolytics, Hematopoietic Agents
Fluid, Electrolyte, and Acid-Base Balance: IV Fluids, Electrolyte Replacement, Acid-Base Regulators
Pediatric and Geriatric Pharmacology: Dosage Calculations, Age-Related Considerations
Pregnancy and Lactation Safety: Teratogenic Risks, FDA Categories, Safe Prescribing
Herbal and Dietary Supplements: Interactions, Adverse Effects, Nursing Implications
Medication Administration and Safety: Rights of Medication Administration, Error Prevention, High-Alert
Medications
Nursing Process in Pharmacology: Assessment, Diagnosis, Planning, Implementation, Evaluation
Patient Education and Adherence: Teaching Strategies, Cultural Considerations, Health Literacy
Updates for 2026:
- Revised to align with the latest 2026/2027 NCLEX-RN test plan and Galen College of Nursing curriculum
updates.
- Incorporated current evidence-based practice guidelines from the American Nurses Association and FDA
approvals.
- Enhanced rationales to include clinical pearls and common misconceptions to deepen understanding.
- Added new questions on emerging drug therapies and biosimilars to reflect contemporary pharmacology.
- Updated drug safety alerts and black box warnings to ensure compliance with the latest regulatory standards.
Page 1
,Abstract:
This exam preparation document is a definitive resource for nursing students enrolled in NU 150 Pharmacology at
Galen College of Nursing, targeting the 2026/2027 academic year. It compiles 200 verified questions that
comprehensively cover the pharmacological knowledge base required for safe and effective nursing practice. The
content is organized systematically, beginning with foundational principles of pharmacokinetics and
pharmacodynamics, then progressing through major drug classifications affecting body systems, and concluding
with specialized populations and medication safety. Each question is paired with a detailed rationale that explains
the correct answer, distractor analysis, and clinical application, thereby promoting higher-order thinking. The
document also includes a breakdown of content areas with corresponding question ranges and weights, ensuring
students can focus their study efforts efficiently. By integrating current guidelines and evidence-based practices,
this resource not only prepares students for exam success but also reinforces lifelong learning in pharmacology. It
is an indispensable tool for achieving a passing score and excelling in nursing practice.
Keywords:
NU 150 Exam 2, Galen Nursing Pharmacology, 2026/2027 NCLEX, Verified Questions, Detailed Rationales, Drug
Classifications, Nursing Implications, Pass Guaranteed
Answer Format:
Each question is presented in multiple-choice format with four options, followed by a comprehensive rationale
explaining why the correct answer is right and why the distractors are incorrect. Rationales include clinical context,
mechanism of action, adverse effects, and nursing considerations to reinforce learning. The answers are clearly
marked as 'Correct Answer' and are verified to align with the latest evidence-based guidelines.
Compliance Checklist:
100% verified questions aligned with the actual NU 150 Exam 2 blueprint
Detailed rationales for every question to support critical thinking
Updated to reflect 2026/2027 NCLEX-RN test plan and Galen curriculum
Includes content area breakdown with question ranges and weights
Pass guaranteed with A+ graded solutions
Content Area Overview:
Content Area Questions Key Topics Weight
Foundations of Pharmacology 1-20 Pharmacokinetics, Pharmacodynamics, Drug 10%
Interactions, Adverse Reactions
Autonomic Nervous System 21-40 Cholinergic, Anticholinergic, Adrenergic, 10%
Drugs Antiadrenergic
Cardiovascular Pharmacology 41-70 Antihypertensives, Antiarrhythmics, Cardiac 15%
Glycosides, Antianginals, Diuretics
Respiratory Pharmacology 71-85 Bronchodilators, Corticosteroids, 7.5%
Expectorants, Antitussives
Endocrine Pharmacology 86-105 Insulin, Oral Hypoglycemics, Thyroid 10%
Medications, Corticosteroids
Neurological and Psychiatric 106-130 Anticonvulsants, Antidepressants, 12.5%
Pharmacology Antipsychotics, Anxiolytics
Analgesics and 131-145 Opioids, NSAIDs, Acetaminophen, Muscle 7.5%
Anti-Inflammatory Agents Relaxants
Antimicrobial Therapy 146-165 Antibiotics, Antivirals, Antifungals, 10%
Antituberculars
Page 2
,Chemotherapy and 166-175 Antineoplastic Agents, Immunomodulators 5%
Immunosuppressants
Gastrointestinal Pharmacology 176-185 Antacids, Antiemetics, Laxatives, 5%
Antidiarrheals, PPIs
Hematologic Pharmacology 186-195 Anticoagulants, Antiplatelets, 5%
Thrombolytics, Hematopoietic Agents
Special Populations and Safety 196-200 Pediatric/Geriatric, Pregnancy/Lactation, 2.5%
Herbal Supplements, Medication Safety
Page 3
, Q1. A patient on a stable dose of warfarin is started on metronidazole for an
anaerobic infection. Three days later, the INR is 5.8. Which pharmacodynamic
principle best explains this interaction?
A. Metronidazole inhibits CYP2C9, reducing warfarin metabolism and increasing its
anticoagulant effect.
B. Metronidazole displaces warfarin from plasma protein binding sites, increasing free
drug concentration.
C. Metronidazole reduces vitamin K absorption from the gut by altering the
microbiome.
D. Metronidazole directly inhibits vitamin K epoxide reductase, potentiating warfarin's
action.
Correct Answer: A. Metronidazole inhibits CYP2C9, reducing warfarin metabolism
and increasing its anticoagulant effect.
Rationale: Metronidazole is a potent inhibitor of CYP2C9, the enzyme that metabolizes the
S-enantiomer of warfarin. This inhibition decreases warfarin clearance, leading to
elevated INR and increased bleeding risk. While other mechanisms may contribute, CYP
inhibition is the primary and most clinically significant interaction.
Why Wrong:
B - Protein binding displacement is a transient effect and not the major mechanism for
this interaction.
C - Metronidazole does not significantly alter vitamin K absorption.
D - Warfarin itself inhibits vitamin K epoxide reductase; metronidazole does not share
this mechanism.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th ed., Ch. 55, pp.
620-621.
Q2. Which medication requires the nurse to obtain a baseline ECG and serum
potassium and magnesium levels prior to initiation, and to reassess the QT interval
after each dose increase?
A. Amiodarone
B. Digoxin
C. Dofetilide
D. Lidocaine
Correct Answer: C. Dofetilide
Rationale: Dofetilide is a class III antiarrhythmic that can cause life-threatening QT
prolongation and torsades de pointes. The FDA-mandated REMS program requires
baseline and follow-up ECG and electrolyte monitoring, with dose adjustments based on
renal function and QT response. This is a unique safety protocol compared to other
antiarrhythmics.
Page 4
